BioPharma Dynamics expands to provide more solutions for cell and gene therapy industry
BioPharma Dynamics have expanded their portfolio for the cell and gene therapy market to offer…
November 29, 2022 - 2 minutes
What’s new
Molecure to conduct cancer treatment trial in Poland
Molecure S.A. says the President of the Polish Office for Registration of Medicinal Products, Medical…
November 28, 2022 - 2 minutes
Deep Science Ventures and AbbVie to create companies to target inflammatory diseases
Deep Science Ventures (DSV), a London-based venture creator, is teaming up with AbbVie, a global…
November 28, 2022 - 2 minutes
Replay receives $1.5M grant for hypoimmunogenic technology platform
Genome writing company Replay has received a $1.56 million grant from the Bill & Melinda…
November 28, 2022 - 3 minutes
Localizing BRCA gene mutations to better treat ovarian cancer
Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1…
November 28, 2022 - 5 minutes
Biomemory raises €5M to advance DNA digital data storage solution
Biomemory, a start-up focused on DNA data synthesis and storage, has closed a €5 million…
November 28, 2022 - 3 minutes
Aptamer opens new facilities to meet growing demand for Optimer technology
Aptamer Group developer of Optimer binders that enable development in the life sciences industry has…
November 28, 2022 - 2 minutes
Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
Monkeypox stigma and racism set to end by renaming to mpox, WHO reports
The World Health Organisation (WHO) said today (November 28) it will begin using mpox, as…
November 28, 2022 - 4 minutes
Breaking barriers to gene therapies for childhood rare diseases
The majority of known rare genetic diseases affect children, and gene therapies could help them…
November 28, 2022 - 5 minutes
STORM Therapeutics doses first patient with drug targeting solid tumors
STORM Therapeutics Ltd, announced today that the first patient in a phase 1 study had…
November 28, 2022 - 2 minutes
Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca
C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca. It is worth…
November 28, 2022 - 3 minutes
